Form 4: Director Jacqueline Millard Receives PACS Group RSU Grant

Director Jacqueline Millard was granted 4,660 restricted stock units in PACS Group, Inc. as part of a standard equity award.

Summary

• Director Jacqueline Millard acquired 4,660 restricted stock units (RSUs) of PACS Group, Inc. common stock.
• The transaction occurred on June 10, 2026.
• The RSUs were granted at a price of $0 per share.
• Following this transaction, the reporting person's total direct beneficial ownership is 15,930 shares of common stock.
• The RSUs vest 100% on the earlier of June 10, 2027, or the date of the next annual meeting, contingent on continued service.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation.

Positives

• Alignment of director interests with shareholders through equity-based compensation.

Negatives

• None identified.

Risks

• Vesting is subject to the reporting person's continued service to the issuer.

Future Outlook

The RSUs are scheduled to vest in full on June 10, 2027, or at the next annual meeting, whichever occurs first.

Industry Context

StockSavvy.ai notes that this is a routine equity grant for a board member, which is standard practice for aligning director incentives with long-term corporate performance in the healthcare services sector.

Comparison to Industry Standards

• Equity-based compensation for directors is a standard governance practice among publicly traded healthcare companies.
• The vesting schedule is consistent with typical annual director compensation cycles.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard director compensation event.

Next Steps

• Vesting of 4,660 RSUs on June 10, 2027, or the date of the next annual meeting.

Key Dates

Keywords

PACS, PACS Group, Form 4, Insider Trading, Restricted Stock Units, Director Compensation